Medikit Co (TSE:7749) ROCE %: 12.53% (As of Dec. 2025)

What is Medikit Co ROCE %?

Medikit Co TSE:7749 -0.18% 81 ROCE % is 12.53% as of Dec. 2025. GuruFocus rates TSE:7749 with a GF Score™ of 81/100 and a GF Value™ of 円3,281.26 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medikit Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 12.53%.

Medikit Co (TSE:7749) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medikit Co ROCE % Related Terms

Medikit Co ROCE % Historical Data

* Premium members only.

The historical data trend for Medikit Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medikit Co ROCE % Chart

Medikit Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

9.70

9.04

10.20

10.19

9.59

Medikit Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															8.37	9.51	10.91	12.53	5.82

81GF Score

Medikit Co Ltd TSE:7749

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medikit Co ROCE % Calculation

Medikit Co's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2025 )		(A: Mar. 2024 )		(A: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2025 )		(A: Mar. 2024 )		(A: Mar. 2025 )
	=	4667.263	/	( ( (50999.47 - 5718.73)	+	(52470.812 - 6159.498) )	/ 2 )
	=	4667.263	/	( (45280.74	+	46311.314)	/ 2 )
	=	4667.263	/	45796.027
	=	10.19 %

Medikit Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	5868.024	/	( ( (52475.251 - 5581.786)	+	(51947.928 - 5186.584) )	/ 2 )
	=	5868.024	/	( ( 46893.465	+	46761.344 )	/ 2 )
	=	5868.024	/	46827.4045
	=	12.53 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 12.53% mean?

Medikit Co (TSE:7749) has a ROCE % of 12.53% as of Dec. 2025.

Is Medikit Co's ROCE % too high?

Medikit Co's current ROCE % is 12.53%. The Medical Devices & Instruments industry median ROCE % is 2.23. Medikit Co's value of 12.53% is 461.9% above this industry median. Overall, Medikit Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Medikit Co's ROCE % compare to ISRG and BDX?

Medikit Co's ROCE % of 12.53% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Medikit Co's value of 12.53% is 461.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medikit Co's current ROCE % of 12.53% is 461.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medikit Co's current ROCE % is 12.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medikit Co stock overvalued right now?

Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,281.26, compared to a current price of 円2,805.00 — trading 14.5% below its estimated fair value. The current ROCE % is 12.53% and 461.9% above the Medical Devices & Instruments industry median of 2.23. Medikit Co's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current ROCE % is 12.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medikit Co (TSE:7749) Overvalued in 2026?

Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued. The current stock price of 円2,805.00 is trading 14.5% below its estimated GF Value™ of 円3,281.26. GuruFocus considers Medikit Co to be Modestly Undervalued.

Key valuation signals for TSE:7749:

ROCE %: 12.53%
GF Value™: 円3,281.26 vs. price of 円2,805.00 (14.5% below fair value)
GF Score™: 81/100 with 2 warning signs
Industry Position: 461.9% above the Medical Devices & Instruments median

No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medikit Co Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TSE:368A TSE:5889 TSE:197A TSE:262A TSE:7979 TSE:3154 TSE:7743 TSE:7775 TSE:3446 TSE:7702 ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Address 1-13-2 ,Yushima, Bunkyo-Ku, Tokyo, JPN, 113 0034

Website http://www.medikit.co.jp

Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.

81GF Score

Get the complete analysis for TSE:7749

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,805.00

Price

円3,281.26

GF Value

View TSE:7749 Analysis

See ROCE % data for all stocks →